Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Vision Care - Medical Devices Pipeline Assessment, 2015

Be the first to review this product

Vision Care - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, 'Vision Care - Medical Devices Pipeline Assessment, 2015' provides an overview of Vision...
You can choose to pay by purchase order during checkout

Availability: In stock

$4,000.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Vision Care - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, 'Vision Care - Medical Devices Pipeline Assessment, 2015' provides an overview of Vision Care currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vision Care pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Vision Care under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vision Care and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vision Care under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 213
Publication date 1 Jan 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Vision Care Overview 13
3 Products under Development 15
3.1 Vision Care - Pipeline Products by Stage of Development 15
3.2 Vision Care - Pipeline Products by Segment 16
3.3 Vision Care - Pipeline Products by Territory 17
3.4 Vision Care - Pipeline Products by Regulatory Path 18
3.5 Vision Care - Pipeline Products by Estimated Approval Date 19
3.6 Vision Care - Ongoing Clinical Trials 20
4 Vision Care - Pipeline Products under Development by Companies 21
4.1 Vision Care Companies - Pipeline Products by Stage of Development 21
4.2 Vision Care - Pipeline Products by Stage of Development 24
5 Vision Care Companies and Product Overview 27
5.1 Adventus Technology Inc Company Overview 27
5.1.1 Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Alcon, Inc. Company Overview 28
5.2.1 Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Apeliotus Ophthalmics Company Overview 32
5.3.1 Apeliotus Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Auburn University Company Overview 34
5.4.1 Auburn University Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 Axcelon Biopolymers Corp. Company Overview 35
5.5.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 Bar-Ilan University Company Overview 36
5.6.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 Bausch & Lomb Incorporated Company Overview 38
5.7.1 Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 38
5.8 Belfanti - Fureder - Meidl technisches Buro f Elektro u Haustechnik GmbH Company Overview 42
5.8.1 Belfanti - Fureder - Meidl technisches Buro f Elektro u Haustechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 Bionic Vision Australia Company Overview 43
5.9.1 Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Body Organ Biomedical Corp. Company Overview 48
5.10.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Children's Hospital Boston Company Overview 50
5.11.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 50
5.12 Consejo Superior de Investigaciones Cientificas Company Overview 51
5.12.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 51
5.13 CooperVision, Inc. Company Overview 53
5.13.1 CooperVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.14 Cornell University Company Overview 54
5.14.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 54
5.15 EP Global Communications, Inc. Company Overview 55
5.15.1 EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.16 eSight Corporation Company Overview 56
5.16.1 eSight Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
5.17 Euclid Systems Corporation Company Overview 57
5.17.1 Euclid Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 57
5.18 Eyegenix Company Overview 58
5.18.1 Eyegenix Pipeline Products & Ongoing Clinical Trials Overview 58
5.19 EyeNetra, Inc. Company Overview 59
5.19.1 EyeNetra, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.20 Eyenovations Company Overview 60
5.20.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview 60
5.21 EyeYon Medical Company Overview 61
5.21.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview 61
5.22 Imperial College London Company Overview 65
5.22.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 65
5.23 iSTAR Medical Company Overview 66
5.23.1 iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview 66
5.24 Johnson & Johnson Vision Care, Inc. Company Overview 67
5.24.1 Johnson & Johnson Vision Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.25 Massachusetts Eye and Ear Infirmary Company Overview 72
5.25.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 72
5.26 Medisse BV Company Overview 73
5.26.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 73
5.27 Mercy Research and Development Company Overview 74
5.27.1 Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview 74
5.28 Microbiosensor Ltd Company Overview 76
5.28.1 Microbiosensor Ltd Pipeline Products & Ongoing Clinical Trials Overview 76
5.29 Monash University Company Overview 77
5.29.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 77
5.30 Nano Retina, Inc. Company Overview 79
5.30.1 Nano Retina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.31 Novartis AG Company Overview 80
5.31.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 80
5.32 Ocular Dynamics, LLC Company Overview 83
5.32.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 83
5.33 Ocutec Limited Company Overview 84
5.33.1 Ocutec Limited Pipeline Products & Ongoing Clinical Trials Overview 84
5.34 PixelOptics, Inc. Company Overview 85
5.34.1 PixelOptics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.35 Pixium Vision Company Overview 86
5.35.1 Pixium Vision Pipeline Products & Ongoing Clinical Trials Overview 86
5.36 Presbia Plc Company Overview 87
5.36.1 Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview 87
5.37 Queensland University of Technology Company Overview 90
5.37.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 90
5.38 ReVision Optics, Inc. Company Overview 91
5.38.1 ReVision Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.39 Stanford University Company Overview 95
5.39.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 95
5.40 Tel Aviv University Company Overview 96
5.40.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 96
5.41 The Hong Kong University of Science and Technology Company Overview 97
5.41.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 97
5.42 The Johns Hopkins University Company Overview 98
5.42.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 98
5.43 UltraVision CLPL Company Overview 100
5.43.1 UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview 100
5.44 University of Auckland Company Overview 101
5.44.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 101
5.45 University of California, San Diego Company Overview 103
5.45.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 103
5.46 University of Florida Company Overview 105
5.46.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 105
5.47 University of Oxford Company Overview 106
5.47.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 106
5.48 University of Rochester Company Overview 108
5.48.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 108
5.49 University of Tennessee, Knoxville Company Overview 110
5.49.1 University of Tennessee, Knoxville Pipeline Products & Ongoing Clinical Trials Overview 110
5.50 University of Valencia Company Overview 112
5.50.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 112
5.51 University of Washington Company Overview 114
5.51.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 114
5.52 Visioneering Technologies, Inc. Company Overview 117
5.52.1 Visioneering Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.53 VISTAKON Pharmaceuticals, LLC Company Overview 123
5.53.1 VISTAKON Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.54 Visual Pathways, Inc. (Inactive) Company Overview 124
5.54.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 124
5.55 Visus Technology, Inc. Company Overview 126
5.55.1 Visus Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 126
5.56 Yolia Health Company Overview 127
5.56.1 Yolia Health Pipeline Products & Ongoing Clinical Trials Overview 127
5.57 Ziemer Ophthalmic Systems AG Company Overview 128
5.57.1 Ziemer Ophthalmic Systems AG Pipeline Products & Ongoing Clinical Trials Overview 128
5.58 ZircLight Inc. Company Overview 129
5.58.1 ZircLight Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
6 Vision Care- Recent Developments 131
7 Appendix 210
7.1 Methodology 210
7.2 About GlobalData 212
7.3 Contact Us 213
7.4 Disclaimer 213

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register